Inventor · disambiguated record
William L. Jorgensen
Also filed as: JORGENSEN WILLIAM · JORGENSEN WILLIAM L
25 granted patents·14 pending applications·137 citations·filing 2006–2025
94Inventor score
Top patents by PatentIndex Score
39 records- 0197US10202343B2MIF modulatorsUNIV YALE·Filed 2017·Granted Feb 12, 2019·35 cites·3 claims
- 0295US9540322B2MIF modulatorsJORGENSEN WILLIAM L·Filed 2011·Granted Jan 10, 2017·38 cites·29 claims
- 0394US9643922B2MIF modulatorsJORGENSEN WILLIAM L·Filed 2010·Granted May 9, 2017·40 cites·32 claims
- 0491US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 0589US11890287B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2021·Granted Feb 6, 2024·2 cites·18 claims
- 0685US11033555B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2016·Granted Jun 15, 2021·3 cites·20 claims
- 0780US12458648B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2023·Granted Nov 4, 2025·0 cites·23 claims
- 0877US2024182419A1Anti-cancer compoundsUNIV SYDNEY·Filed 2024·Application pending·0 cites
- 0975US11939296B2Anti-cancer compoundsUNIV SYDNEY·Filed 2022·Granted Mar 26, 2024·0 cites·16 claims
- 1074US8492415B2Azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV)JORGENSEN WILLIAM L·Filed 2008·Granted Jul 23, 2013·1 cites·68 claims
- 1174US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 1270US11584717B2MIF modulatorsUNIV YALE·Filed 2018·Granted Feb 21, 2023·0 cites·3 claims
- 1370US10968198B2Biaryltriazole inhibitors of macrophage migration inhibitory factorUNIV YALE·Filed 2019·Granted Apr 6, 2021·1 cites·22 claims
- 1470US2020377457A1Mif modulatorsUNIV YALE·Filed 2020·Application pending·0 cites
- 1568US11472774B2Anti-cancer compoundsUNIV SYDNEY·Filed 2019·Granted Oct 18, 2022·0 cites·11 claims
- 1668US9018209B2Compounds and methods for the treatment of viruses and cancerJORGENSEN WILLIAM L·Filed 2006·Granted Apr 28, 2015·1 cites·29 claims
- 1766US10899739B2Macrophage migration inhibitory factor inhibitors, and methods of making and using sameUNIV YALE·Filed 2018·Granted Jan 26, 2021·0 cites·14 claims
- 1865US12428380B2CompoundsPsylo Pty Ltd·Filed 2024·Granted Sep 30, 2025·0 cites·1 claims
- 1965US12415804B2Compounds for activating a serotonin receptorPsylo Pty Ltd·Filed 2024·Granted Sep 16, 2025·0 cites·1 claims
- 2065US11999723B2Pyrazole-containing macrophage migration inhibitory factor inhibitorsUNIV YALE·Filed 2022·Granted Jun 4, 2024·0 cites·11 claims
- 2162US10336721B2Biaryltriazole inhibitors of macrophage migration inhibitory factorUNIV YALE·Filed 2016·Granted Jul 2, 2019·1 cites·25 claims
- 2262US2023330103A1Non-peptide oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2022·Application pending·0 cites
- 2361US2025034112A1Improved selective jak2 inhibitors and methods of useUNIV YALE·Filed 2022·Application pending·0 cites
- 2461US2025101038A1CompoundsPsylo Pty Ltd·Filed 2022·Application pending·0 cites
- 2561US2025353818A1CompoundsPsylo Pty Ltd·Filed 2025·Application pending·0 cites
- 2661US2025074873A1CompoundsPsylo Pty Ltd·Filed 2022·Application pending·0 cites
- 2761US2025361233A1Compounds For Activating Serotonin ReceptorPsylo Pty Ltd·Filed 2025·Application pending·0 cites
- 2860US11491165B2Non-peptide oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2019·Granted Nov 8, 2022·0 cites·16 claims
- 2960US2021107896A1Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 3059US12110278B2Selective JAK2 pseudokinase ligands and methods of useUNIV YALE·Filed 2021·Granted Oct 8, 2024·0 cites·21 claims
- 3158US11465991B2Pyrazole-containing macrophage migration inhibitory factor inhibitorsUNIV YALE·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 3258US2024092759A1Non-Covalent Inhibitors of the Main Protease of SARS-CoV-2 and Methods of UseUNIV YALE·Filed 2022·Application pending·0 cites
- 3357US2023399303A1Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using SameUNIV YALE·Filed 2021·Application pending·0 cites
- 3455US9914709B2Compositions and methods of treating HIV-1 infections using sameUNIV YALE·Filed 2014·Granted Mar 13, 2018·0 cites·18 claims
- 3555US9382245B2Compounds and methods for treating HIV infectionsUNIV YALE·Filed 2014·Granted Jul 5, 2016·0 cites·19 claims
- 3654US2019127359A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2018·Application pending·0 cites
- 3752US2012040974A1Mif modulatorsJORGENSEN WILLIAM L·Filed 2009·Application pending·0 cites
- 3848US9487476B2Catechol diethers as potent anti-HIV agentsUNIV YALE·Filed 2012·Granted Nov 8, 2016·0 cites·39 claims
- 3940US11414459B2Metabolite inspired selective oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2018·Granted Aug 16, 2022·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when William L. Jorgensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →